Pharmaceutical major Pfizer has selected Oracle solutions to manage and monitor its more than 300 clinical trials a year.
The US-based Oracle will supply Health Sciences InForm Cloud Service and the Oracle Siebel Clinical Trial Management and Monitoring Cloud Service.
Rob Goodwin, vice president of Pfizer Global Product Development, Center of Excellence, said: “Clinical teams will be able to access study data through Oracle’s single platform cloud service, eliminating the need to send data back and forth to CROs, saving us time and reducing the cost of our clinical studies.”
Oracle Health Sciences InForm Cloud Service enables Pfizer to benefit from over 100,000 investigator sites already trained in InForm, while increasing site data satisfaction.
Oracle Health Sciences InForm Cloud Service will enable Pfizer to ensure control its data and provide measurable efficiency and productivity gains in data management and remote monitoring. Study templates and library management capabilities within Oracle Health Sciences InForm will enable Pfizer to accelerate the study-build process and result in faster trial implementation.
Steve Rosenberg, senior vice president, Oracle Health Sciences, said: “Oracle Health Sciences helps leading pharmas — such as Pfizer — not only to standardize and optimize their clinical study processes, but also to be prepared with value-based clinical innovation solutions that enable them for the future of data collection.”
Pfizer will utilize Oracle Siebel Clinical Trial Management and Monitoring Cloud Service, including Oracle Siebel Clinical Trial Management System, Oracle Health Sciences Clinical Development Analytics, and risk-based monitoring (RBM) functionality to provide new insights into trial management and help increase efficiency of the monitoring workforce.
